Overview: Stool Comprehensive Antigen ICT 2 TestIntroduction: The Stool Comprehensive Antigen ICT 2 Test screens stool antigens to diagnose gastrointestinal infections, causing abdominal pain. Following 2023 IDSA guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in clinical pathology for patients with suspected gastrointestinal infections.
Other Names: Stool Antigen ICT Assay, Gastrointestinal Antigen Test.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: Stool antigen testing began in the 1990s with rapid diagnostics. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Screens stool antigens to diagnose gastrointestinal infections, guides treatment, and evaluates patients with abdominal pain.
Test Parameters: 1. Antigen Presence
Pretest Condition: No fasting required. Collect stool. Report history of abdominal pain or gastrointestinal symptoms.
Specimen: Stool (sterile container, 5-10 gm). Transport in a biohazard container.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document abdominal pain, diarrhea, or history of gastrointestinal infections. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, gastrointestinal infection implications, and risks of sample collection.
Procedural Considerations: Uses immunochromatographic assay (ICT) to screen for pathogen antigens. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for gastrointestinal infection diagnosis.
Factors Affecting Result Accuracy: Improper stool collection or delayed transport can affect results. Antibiotic use may reduce sensitivity.
Clinical Significance: Positive antigens confirm gastrointestinal infection, guiding antibiotic or supportive therapy. Negative results may require culture or PCR.
Specialist Consultation: Consult an infectious disease specialist or gastroenterologist for result interpretation and treatment planning.
Additional Supporting Tests: Stool culture, PCR, or endoscopy to confirm gastrointestinal infection diagnosis.
Test Limitations: Limited to detectable antigens; clinical correlation is needed. Sample quality affects sensitivity.
References: IDSA Gastrointestinal Infection Guidelines, 2023; Clinical Infectious Diseases, Shane AL, 2022.
